Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HIV-1 protease: maturation, enzyme specificity, and drug resistance.

× No keyword cloud information.

44 in total

1. Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.

Authors: Jane M Sayer; Fengling Liu; Rieko Ishima; Irene T Weber; John M Louis
Journal: J Biol Chem Date: 2008-02-15 Impact factor: 5.157

2. Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.

Authors: Liangqun Huang; Jane M Sayer; Marie Swinford; John M Louis; Chaoping Chen
Journal: J Virol Date: 2009-05-20 Impact factor: 5.103

3. Room Temperature Neutron Crystallography of Drug Resistant HIV-1 Protease Uncovers Limitations of X-ray Structural Analysis at 100 K.

Authors: Oksana Gerlits; David A Keen; Matthew P Blakeley; John M Louis; Irene T Weber; Andrey Kovalevsky
Journal: J Med Chem Date: 2017-02-28 Impact factor: 7.446

4. Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1.

Authors: Yasuhiro Koh; Manabu Aoki; Matthew L Danish; Hiromi Aoki-Ogata; Masayuki Amano; Debananda Das; Robert W Shafer; Arun K Ghosh; Hiroaki Mitsuya
Journal: J Virol Date: 2011-08-03 Impact factor: 5.103

5. Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease.

Authors: John M Louis; Rieko Ishima; Annie Aniana; Jane M Sayer
Journal: Protein Sci Date: 2009-12 Impact factor: 6.725

6. Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors.

Authors: John M Louis; Annie Aniana; Irene T Weber; Jane M Sayer
Journal: Proc Natl Acad Sci U S A Date: 2011-05-16 Impact factor: 11.205

7. Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors: Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal: J Virol Date: 2002-10 Impact factor: 5.103

8. Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.

Authors: Jane M Sayer; John M Louis
Journal: Proteins Date: 2009-05-15

9. Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.

Authors: Liangqun Huang; Alyssa Hall; Chaoping Chen
Journal: Retrovirology Date: 2010-03-23 Impact factor: 4.602

10. Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.

Authors: Liangqun Huang; Chaoping Chen
Journal: AIDS Res Ther Date: 2010-07-28 Impact factor: 2.250